Market revenue in 2020 | USD 72.2 million |
Market revenue in 2028 | USD 150.0 million |
Growth rate | 9.6% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 66.34% in 2020. Horizon Databook has segmented the Mexico chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
The growth of Mexican market can be attributed to high prevalence of various diseases, such as cardiovascular & infectious diseases and cancer, which has increased demand for CLIA products for diagnosis.
In addition, improving healthcare infrastructure and increasing adoption of advanced CLIA systems are among factors expected to support the market growth in the country. Furthermore, increase in approvals and launch of novel CLIA solutions in the country are expected to fuel the market growth.
For instance, in June 2020, UK-based Edinburgh Genetics received COFEPRIS approval for its new COVID-19 immunoassay antibodies testing kits. Moreover, in September 2018, Ortho Clinical Diagnostics launched Vitros Anti-T. cruzi Assay for the early detection of Chagas disease.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into Mexico chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account